Home › NCT05010265
An Ethical Approach to Detecting Covert Consciousness
RecruitingObservational study
An Ethical Approach to Detecting Covert Consciousness: Data-Driven Neuroethics for Consciousness Detection (DECODE)
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Patients with prior or ongoing participation as subject in a research study using neurotechnologies for diagnosis and prognosis of disorders of consciousness (DoC) at Mass General Brigham * Patients capable of understanding and answering questions in English * Patients cble to provide informed consent * Patients for whom MRI / EEG are administered for clinical detection of consciousness and/or neuroprognostication * Family member or surrogate caregiver of patients who previously participated or are currently participating in a research study using neurotechnologies for diagnosis and prognosis of DoC at Mass General Brigham. * Family Members / Surrogates capable of understanding and answering questions in English * Family Members / Surrogates able to provide informed consent * Family member or surrogate caregiver of patients for whom MRI / EEG are administered for clinical detection of consciousness and/or neuroprognostication * Research Investigators involved with research responsibilities in designing or testing neurotechnologies on patients with DoC. * Clinicians with clinical responsibilities caring for patients in behaviorally unresponsive state, defined as coma, vegetative state (VS), and low-level minimally conscious state (MCS). * Selected leaders and advisors (Community and Thought Leaders) from brain injury associations and advocacy organizations, and policy-makers involved in decision-making impacting patients with DoC. Exclusion Criteria: None
About the study
This study aims to develop an ethical approach to developing and deploying novel neurotechnologies to aid in the detection of consciousness and prediction of recovery after brain injury.
What is being tested
- Clinician Questionnaire (other)
- Semi Structured Interviews (other)
Sponsor: Massachusetts General Hospital · Participants: 70 · Started: Feb 1, 2022
Contact the study team
- Michael Young, MD · Phone: 617-724-6352
- Brian Edlow, MD · Phone: 617-724-6352
Official record on ClinicalTrials.gov — NCT05010265
Locations in the U.S.
| Massachusetts | Massachusetts General Hospital, Boston |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.